| Title | Author(s) | Year | View Count |
 | Patients with diffuse large B-cell lymphoma of germinal center origin with BCL2 translocations have poor outcome, irrespective of MYC status: a report from an International DLBCL rituximab-CHOP Consortium Program Study | Visco, C; Tzankov, A; Xu-Monette, ZY; Miranda, RN; Tai, YC; Li, Y; Liu, WM; d'Amore, ES; Montes-Moreno, S; Dybkaer, K; Chiu, A; Orazi, A; Zu, Y; Bhagat, G; Wang, HY; Dunphy, CH; Hsi, ED; Zhao, XF; Choi, WL; Zhao, X; van Krieken, JH; Huang, Q; Ai, W; O'Neill, S; Ponzoni, M; Ferreri, AJ; Kahl, BS; Winter, JN; Go, RS; Dirnhofer, S; Piris, MA; Moller, MB; Wu, L; Medeiros, LJ; Young, KH | 2013 | 41 |
| CD30 expression defines a novel subset of diffuse large B-cell lymphoma with favorable prognosis and distinct gene expression signature: a report from The International DLBCL Rituximab-CHOP Consortium Program Study | Hu, S; Xu-Monette, ZY; Balasubramanyam, A; Manyam, GC; Visco, C; Tzankov, A; Liu, WM; Miranda, RN; Zhang, L; Montes-Moreno, S; Dybkaer, K; Chiu, A; Orazi, A; Zu, Y; Bhagat, G; Richards, KL; Hsi, ED; Choi, WL; van Krieken, JH; Huang, Q; Huh, J; Ai, W; Ponzoni, M; Ferreri, AJ; Zhao, X; Winter, JN; Zhang, M; Li, L; Moller, MB; Piris, MA; Li, Y; Go, RS; Wu, L; Medeiros, LJ; Young, KH | 2013 | 42 |
| Mutational profile and prognostic significance of TP53 in diffuse large B-cell lymphoma patients treated with R-CHOP: report from an International DLBCL Rituximab-CHOP Consortium Program Study | Xu-Monette, ZY; Wu, L; Visco, C; Tai, YC; Tzankov, A; Liu, WM; Montes-Moreno, S; Dybkaer, K; Chiu, A; Orazi, A; Zu, Y; Bhagat, G; Richards, KL; Hsi, ED; Zhao, XF; Choi, WL; Zhao, X; van Krieken, JH; Huang, Q; Huh, J; Ai, W; Ponzoni, M; Ferreri, AJ; Zhou, F; Kahl, BS; Winter, JN; Xu, W; Li, J; Go, RS; Li, Y; Piris, MA; Moller, MB; Miranda, RN; Abruzzo, LV; Medeiros, LJ; Young, KH | 2012 | 32 |
 | Comprehensive gene expression profiling and immunohistochemical studies support application of immunophenotypic algorithm for molecular subtype classification in diffuse large B-cell lymphoma: a report from the International DLBCL Rituximab-CHOP Consortium Program Study | Visco, C; Li, Y; Xu-Monette, ZY; Miranda, RN; Green, TM; Li, Y; Tzankov, A; Wen, W; Liu, WM; Kahl, BS; d'Amore, ESG; Montes-Moreno, S; Dybkaer, K; Chiu, A; Tam, W; Orazi, A; Zu, Y; Bhagat, G; Winter, JN; Wang, HY; O'Neill, S; Dunphy, CH; Hsi, ED; Zhao, XF; Go, RS; Choi, WWL; Zhou, F; Czader, M; Tong, J; Zhao, X; van Krieken, JH; Huang, Q; Ai, W; Etzell, J; Ponzoni, M; Ferreri, AJM; Piris, MA; Moller, MB; Bueso-Ramos, CE; Medeiros, LJ; Wu, L; Young, KH | 2012 | 76 |
| The t(14;18)(q32;q21) characterizes a subset of patients with diffuse large-B cell lymphoma of germinal center origin with poor outcome: report from the International DLBCL Rituximab-CHOP Consortium Program Study | Visco, C; Tzankov, A; Xu-Monette, ZY; Miranda, RN; d'Amore, ESG; Montes-Moreno, S; Dybkae, K; Chiu, A; Tam, W; Orazi, A; Zu, Y; Bhagat, G; Kahl, BS; Winter, JN; Wang, HY; Dunphy, CH; Hsi, ED; Zhao, FX; Go, RS; Choi, WWL; Zhou, F; Czader, M; Zhao, X; Van Krieken, JHJM; Huang, Q; Ai, W; Etzell, JE; Ponzoni, M; Ferreri, AJM; Piris, MA; Møller, MB; Bueso-Ramos, CE; Medeiros, LJ; Young, KH | 2011 | 42 |
| Clinical Impact Of Tp53 Gene Mutations In Diffuse Large B-cell Lymphoma (dlbcl): An International Dlbcl Rituxan-chop Consortium Program Study | Young, KH; Patten, N; Truong, S; Eickhoff, J; Rocque, GL; Malik, JT; Li, Y; Kanehira, K; Twohig, M; Rehrauer, WM; Waknitz, MA; Kahl, BS; Moller, MB; Tzankov, A; Moreno, SM; Piris, MA; Visco, C; Dybkaer, K; Chiu, A; Orazi, A | 2009 | 79 |
| Clinical Impact Of TP53 Gene Mutations In Diffuse Large B-cell Lymphoma (DLBCL): An International DLBCL Rituxan-CHOP Consortium Program Study | Young, KH; Patten, N; Truong, S; Eickhoff, J; Rocque, GL; Malik, JT; Li, Y; Kanehira, K; Twohig, M; Rehrauer, WM; Waknitz, MA; Kahl, BS; Moller, MB; Tzankov, A; Moreno, SM; Piris, MA; Visco, C; Dybkaer, K; Chiu, A; Attilio, O; Chang, JC; Bhagat, G; Winter, JN; Wang, HY; Dunphy, C; O'Neill, S; Hsi, ED; Zhao, X; Hunt, K; Chen, WL; Go, RS; Choi, WL; Zhou, F; Czader, M; Li, Y; Selvaggi, S; Malter, JS; Wu, L | 2009 | 114 |
| A new immunostain algorithm classifies diffuse large B-cell lymphoma into molecular subtypes with high accuracy | Choi, WWL; Weisenburger, DD; Greiner, TC; Piris, MA; Banham, AH; Delabie, J; Braziel, RM; Geng, H; Iqbal, J; Lenz, G; Vose, JM; Hans, CP; Fu, K; Smith, LM; Li, M; Liu, Z; Gascoyne, RD; Rosenwald, A; Ott, G; Rimsza, LM; Campo, E; Jaffe, ES; Jaye, DL; Staudt, LM; Chan, WC | 2009 | 139 |
|
